Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Stem Cell and Regenerative Medicine Research
Frontiers in Stem Cell and Regenerative Medicine Research is not currently indexed in Scopus. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 2352-7633Verify ISSN ↗2467-9593Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Frontiers in Stem Cell and Regenerative Medicine Research indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2022 (also 2020)).
What is the impact factor of Frontiers in Stem Cell and Regenerative Medicine Research?
Frontiers in Stem Cell and Regenerative Medicine Research has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.133, quartile Q4, with an H-index of 1.
Who publishes Frontiers in Stem Cell and Regenerative Medicine Research and what is its ISSN?
Frontiers in Stem Cell and Regenerative Medicine Research is published by Bentham Science Publishers. Its print ISSN is 2352-7633 and its online ISSN is 2467-9593.
Is Frontiers in Stem Cell and Regenerative Medicine Research in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Frontiers in Stem Cell and Regenerative Medicine Research open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Frontiers in Stem Cell and Regenerative Medicine Research for 2 years, between 2020 and 2022, with 1 year in that span missing. Coverage ended in 2022, 4 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 39 works and 14 citations for the title. Its most recent paper is from 2022, in line with the end of Scopus coverage in 2022, which suggests the journal stopped publishing around then.
How well cited is Frontiers in Stem Cell and Regenerative Medicine Research? — open metrics via OpenAlex
Frontiers in Stem Cell and Regenerative Medicine Research has an h-index of 2 and a 2-year mean of 0 citations per paper (OpenAlex).
Frontiers in Stem Cell and Regenerative Medicine Research published 9 papers in 2022; its busiest recent year was 2017 with 10. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Frontiers in Stem Cell and Regenerative Medicine Research? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2022. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2022
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.